Latest

tauopathies

Neurology Neuroscience Neuroscience Business

·November 4, 2017·7 min read

Cortice Biosciences Announces Presentation of Results from Placebo-Controlled Phase 1 Clinical Trials Evaluating TPI 287 for Treatment of Alzheimer’s Disease and Related Tauopathies

Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule stabilizing agent, for the treatment of Alzheimer’s disease, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS).

Featured Neurology

·October 13, 2016·4 min read

Untangling a Cause of Memory Loss in Neurodegenerative Diseases

A new study identifies a possible therapeutic target for memory loss in some neurodegenerative diseases, including Alzheimer's.

Featured Genetics Neurology

·December 21, 2015·4 min read

Slowing Alzheimer’s by Speeding Up Brain’s Waste Disposal

Researchers identify a therapeutic target for clearing toxic proteins in Alzheimer's and other neurodegenerative diseases.

Image of a stained hippcampal slice from a mouse.

Featured Neurology

·September 21, 2015·4 min read

Old Rheumatoid Arthritis Drug Offers New Hope for Alzheimer’s Disease

According to a new study, a drug previously prescribed for rheumatoid arthritis have been found to successfully reverse tau related symptoms in animal models of dementia.

Featured Neurology

·September 2, 2015·4 min read

How Tau Accumulates and Caused Neurodegenerative Disorders

A new study reports appoptosin initiates a path that leads to tau accumulation in neurodegenerative disorders.

The image shows a PET scan of a brain of a person with Alzheimer's disease.

Featured Neuroscience

·February 15, 2013·2 min read

Neuronal Activity Induces Tau Release from Healthy Neurons

Researchers discover neuronal activity can stimulate tau release from healthy neurons in the absence of cell death. The study shows treatment of neurons with known biological signaling molecules increases the release of tau into the culture medium.